Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of LX9211 in Participants With Postherpetic Neuralgia

ClinicalTrials.gov ID: NCT04662281

Public ClinicalTrials.gov record NCT04662281. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 1:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of LX9211 in the Treatment of Postherpetic Neuralgia (RELIEF-PHN1)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Evaluation of the efficacy of LX9211 compared to placebo in reducing pain related to postherpetic neuralgia over an 11 week assessment period.

Study identification

NCT ID
NCT04662281
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Lexicon Pharmaceuticals
Industry
Enrollment
79 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 10, 2020 (Actual)
Primary completion
Nov 18, 2022 (Actual)
Completion
Dec 28, 2022 (Actual)
Last update posted
Feb 13, 2026

2020 – 2022

United States locations

U.S. sites
22
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Lexicon Investigational Site Scottsdale Arizona 85258 —
Lexicon Investigational Site Tucson Arizona 85741 —
Lexicon Investigational Site Greenbrae California 94904 —
Lexicon Investigational Site Brandon Florida 33511 —
Lexicon Investigational Site (113) Miami Florida 33032 —
Lexicon Investigational Site Miami Florida 33144 —
Lexicon Investigational Site Miami Florida 33174 —
Lexicon Investigational Site Ormond Beach Florida 32174 —
Lexicon Investigational Site Winter Park Florida 32789 —
Lexicon Investigational Site (147) Marietta Georgia 30060 —
Lexicon Investigational Site Flossmoor Illinois 60422 —
Lexicon Investigational Site Wauconda Illinois 60084 —
Lexicon Investigational Site Boston Massachusetts 02131 —
Lexicon Investigational Site Canton Michigan 48187 —
Lexicon Investigational Site Hazelwood Missouri 63042 —
Lexicon Investigational Site Albuquerque New Mexico 87102 —
Lexicon Investigational Site (148) Cary North Carolina 27518 —
Lexicon Investigational Site Jenkintown Pennsylvania 19046 —
Lexicon Investigational Site Baytown Texas 77521 —
Lexicon Investigational Site Victoria Texas 77901 —
Lexicon Investigational Site Salt Lake City Utah 84102 —
Lexicon Investigational Site Kenosha Wisconsin 53144 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04662281, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 13, 2026 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04662281 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →